Spending growth on retail prescriptions drugs in the US slowed to 1.3% in 2016 after recording much stronger growth rates of 8.9% and 12.4% in 2015 and 2014 respectively, according to actuaries at the Centers for Medicare and Medicaid Services. Retail drug spending reached $328.6bn last year.
The deceleration reflects fewer new drug approvals and lower hepatitis C and diabetes drug spending, CMS says in its latest...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?